141 related articles for article (PubMed ID: 35542655)
21. Long non‑coding RNA DLEU1 promotes cell proliferation of glioblastoma multiforme.
Wang J; Quan X; Peng D; Hu G
Mol Med Rep; 2019 Aug; 20(2):1873-1882. PubMed ID: 31257517
[TBL] [Abstract][Full Text] [Related]
22. Screening for long noncoding RNAs associated with oral squamous cell carcinoma reveals the potentially oncogenic actions of DLEU1.
Nishiyama K; Maruyama R; Niinuma T; Kai M; Kitajima H; Toyota M; Hatanaka Y; Igarashi T; Kobayashi JI; Ogi K; Dehari H; Miyazaki A; Yorozu A; Yamamoto E; Idogawa M; Sasaki Y; Sugai T; Tokino T; Hiratsuka H; Suzuki H
Cell Death Dis; 2018 Aug; 9(8):826. PubMed ID: 30069008
[TBL] [Abstract][Full Text] [Related]
23. SP1-DLEU1-miR-4429 feedback loop promotes cell proliferative and anti-apoptotic abilities in human glioblastoma.
Liu X; Chen R; Liu L
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31713587
[TBL] [Abstract][Full Text] [Related]
24. LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3.
Liu T; Han Z; Li H; Zhu Y; Sun Z; Zhu A
Mol Cancer; 2018 Aug; 17(1):118. PubMed ID: 30098595
[TBL] [Abstract][Full Text] [Related]
25. Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy.
Lv QL; Wang LC; Li DC; Lin QX; Shen XL; Liu HY; Li M; Ji YL; Qin CZ; Chen SH
Front Pharmacol; 2020; 11():560543. PubMed ID: 33362537
[TBL] [Abstract][Full Text] [Related]
26. LncRNA DLEU1 is overexpressed in premature ovarian failure and sponges miR-146b-5p to increase granulosa cell apoptosis.
Zheng C; Liu S; Qin Z; Zhang X; Song Y
J Ovarian Res; 2021 Nov; 14(1):151. PubMed ID: 34740384
[TBL] [Abstract][Full Text] [Related]
27. LncRNA SNHG6 Promotes Wilms' Tumor Progression Through Regulating miR-429/FRS2 Axis.
Wang Y; Liu J; Yao Q; Wang Y; Liu Z; Zhang L
Cancer Biother Radiopharm; 2024 May; 39(4):264-275. PubMed ID: 33481659
[No Abstract] [Full Text] [Related]
28. DLEU1 promotes oral squamous cell carcinoma progression by activating interferon-stimulated genes.
Hatanaka Y; Niinuma T; Kitajima H; Nishiyama K; Maruyama R; Ishiguro K; Toyota M; Yamamoto E; Kai M; Yorozu A; Sekiguchi S; Ogi K; Dehari H; Idogawa M; Sasaki Y; Tokino T; Miyazaki A; Suzuki H
Sci Rep; 2021 Oct; 11(1):20438. PubMed ID: 34650128
[TBL] [Abstract][Full Text] [Related]
29. LINC00667 promotes Wilms' tumor metastasis and stemness by sponging miR-200b/c/429 family to regulate IKK-β.
Liu P; Chen S; Huang Y; Xu S; Song H; Zhang W; Sun N
Cell Biol Int; 2020 Jun; 44(6):1382-1393. PubMed ID: 32129525
[TBL] [Abstract][Full Text] [Related]
30. Silencing of Long Noncoding RNA SNHG6 Inhibits Esophageal Squamous Cell Carcinoma Progression via miR-186-5p/HIF1α Axis.
Du F; Guo T; Cao C
Dig Dis Sci; 2020 Oct; 65(10):2844-2852. PubMed ID: 31853782
[TBL] [Abstract][Full Text] [Related]
31. DLEU1 promotes cell survival by preventing DYNLL1 degradation in esophageal squamous cell carcinoma.
Li Q; Zhang Z; Jiang H; Hou J; Chai Y; Nan H; Li F; Wang L
J Transl Med; 2022 May; 20(1):245. PubMed ID: 35619131
[TBL] [Abstract][Full Text] [Related]
32. Long noncoding RNA DLEU1 promotes proliferation and glycolysis of gastric cancer cells via APOC1 upregulation by recruiting SMYD2 to induce trimethylation of H3K4 modification.
Xu H; Ba Z; Liu C; Yu X
Transl Oncol; 2023 Oct; 36():101731. PubMed ID: 37478669
[TBL] [Abstract][Full Text] [Related]
33. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10691-10698. PubMed ID: 31858537
[TBL] [Abstract][Full Text] [Related]
34. Upregulation of Serum lncRNA DLEU1 Predicts Progression of Premalignant Endometrial Lesion and Unfavorable Clinical Outcome of Endometrial Cancer.
Shan L; Zhao T; Wang Y
Technol Cancer Res Treat; 2020; 19():1533033820965589. PubMed ID: 33327893
[TBL] [Abstract][Full Text] [Related]
35. DLEU1: A Functional Long Noncoding RNA in Tumorigenesis.
Song C; Zhang J; Zhao Z; Yang Y; Meng D; Wang J; Guo C; Yuan C
Curr Pharm Des; 2020; 26(15):1742-1748. PubMed ID: 31969095
[TBL] [Abstract][Full Text] [Related]
36. miR-483-5p Targets MKNK1 to Suppress Wilms' Tumor Cell Proliferation and Apoptosis In Vitro and In Vivo.
Liu K; He B; Xu J; Li Y; Guo C; Cai Q; Wang S
Med Sci Monit; 2019 Feb; 25():1459-1468. PubMed ID: 30798328
[TBL] [Abstract][Full Text] [Related]
37. Survival‑related DLEU1 is associated with HPV infection status and serves as a biomarker in HPV‑infected cervical cancer.
Dong A; Xu B; Wang Z; Miao X
Mol Med Rep; 2022 Mar; 25(3):. PubMed ID: 35014679
[TBL] [Abstract][Full Text] [Related]
38. Long Non-Coding RNA DLEU1 Up-Regulates BIRC6 Expression by Competitively Sponging miR-381-3p to Promote Cisplatin Resistance in Nasopharyngeal Carcinoma.
Li H; Huang J; Yu S; Lou Z
Onco Targets Ther; 2020; 13():2037-2045. PubMed ID: 32214823
[TBL] [Abstract][Full Text] [Related]
39. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
Huang X; Gao Y; Qin J; Lu S
Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
[TBL] [Abstract][Full Text] [Related]
40. Long Noncoding RNA FEZF1-AS1 Promotes Osteosarcoma Progression by Regulating the miR-4443/NUPR1 Axis.
Zhou C; Xu J; Lin J; Lin R; Chen K; Kong J; Shui X
Oncol Res; 2018 Oct; 26(9):1335-1343. PubMed ID: 29510778
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
